The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISAL 2019 | Progress in AML & research at the University of Düsseldorf
Thomas Schröder
• 15 Mar 2019
Thomas Schröder, MD, of the University of Düsseldorf, Düsseldorf, Germany, discusses progress in acute myeloid leukemia (AML) and the ongoing research into myeloid disorders at his lab. This intervew took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.
